Actos Lawsuit Lawyers
In June of 2011, the FDA issued a new warning of increased bladder cancer risk associated with use of the diabetes drug Actos (pioglitazone), after analysis of a 5-year study of the drug by manufacturer Takeda Pharmaceuticals.
If you or a loved one have been injured on dialysis, please contact us today for a free initial consultation to review your potential claim, toll free at 800-782-8492, or fill out the contact section on the left.
The results of the Actos study showed an increased risk of bladder cancer among long-term users of the drug and a greater risk of bladder cancer among users exposed to the highest cumulative dose. The FDA then required Takeda to add new information about an increased risk of bladder cancer to the Warnings and Precautions section of the Actos label.
The FDA has also acknowledged the result of a 10-year study in France which also showed an increased risk of bladder cancer with Actos use. As a result of this study, France has banned the sale of Actos, and Germany has advised doctors not to prescribe Actos to new patients.
Symptoms of bladder cancer can include:
- Blood in the urine
- Bone pain or tenderness
- Painful urination
- Urinary frequency
- Urinary urgency
- Urine leakage (incontinence)
- Weight loss
Contact Goldenberg Heller & Antognoli, P.C.
If you or a loved one have been diagnosed with bladder cancer, please contact us today at 618-656-5150 or toll free at 800-782-8492 to schedule a free initial consultation with one of our experienced Actos attorneys. We handle all pharmaceutical litigation on a contingency fee basis. You pay nothing for our services unless we obtain a settlement or an award on your behalf.